Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription factor HES5 (Hairy and enhancer of split 5) is a basic helix-loop-helix (bHLH) protein that serves as a primary downstream effector of the Notch signaling pathway [UniProt: Q5TA89]. It functions as a transcriptional repressor, typically binding to N-box sequences in the promoters of proneural genes to inhibit their expression and maintain stem cells in an undifferentiated state [NCBI Gene: 388585]. In the central nervous system, HES5 plays a critical role in regulating the balance between neural stem cell self-renewal and differentiation into neurons or glia [PubMed: 17629545]. Dysregulation of HES5 is frequently observed in various malignancies, including glioblastoma and medulloblastoma, where its overexpression promotes tumor cell stemness and resistance to therapy [PubMed: 31213565]. While small molecule inhibitors directly targeting HES5 are challenging to develop due to its nature as a transcription factor, HES5 mRNA represents a viable therapeutic target for RNA-based modalities like siRNA or antisense oligonucleotides [PubMed: 28671665]. By reducing HES5 levels, these therapies aim to induce differentiation in cancer stem cells or restore normal developmental programs [PubMed: 25661153].
RNA interference (siRNA) or antisense oligonucleotides (ASO) targeting HES5 mRNA to prevent translation of the HES5 repressor protein, thereby promoting cellular differentiation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription factor HES5 (HES5).